Lucia Blesa-Maure

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Clinical Impact and Prognostic Value of Alzheimer Disease Biomarkers in the Very Old.

Clinical Impact and Prognostic Value of Alzheimer Disease Biomarkers in the Very Old.

Journal: Neurology

Published: June 17, 2026

Evidence for bilingualism as a cognitive reserve factor in biomarker-confirmed Alzheimer's disease.

Evidence for bilingualism as a cognitive reserve factor in biomarker-confirmed Alzheimer's disease.

Journal: medRxiv : the preprint server for health sciences

Published: April 10, 2026

Amyloid-linked versus age-driven copathologies in Alzheimer's dementia: differential associations with APOE ε4.

Amyloid-linked versus age-driven copathologies in Alzheimer's dementia: differential associations with APOE ε4.

Journal: Research square

Published: March 27, 2026

CSF and plasma tau biomarkers in the Down syndrome-Alzheimer's disease continuum.

CSF and plasma tau biomarkers in the Down syndrome-Alzheimer's disease continuum.

Journal: EBioMedicine

Published: January 22, 2026

Peak width of skeletonized mean diffusivity reveals early and multifactorial white matter injury across sporadic and Down syndrome-associated Alzheimer's disease.

Peak width of skeletonized mean diffusivity reveals early and multifactorial white matter injury across sporadic and Down syndrome-associated Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: January 20, 2026

Characterizing circadian rest-activity rhythm patterns across Alzheimer's disease continuum in Down syndrome.

Characterizing circadian rest-activity rhythm patterns across Alzheimer's disease continuum in Down syndrome.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: January 08, 2026

The predictive power of neuropsychological measures in MCI: early detection of dementia conversion.

The predictive power of neuropsychological measures in MCI: early detection of dementia conversion.

Journal: Frontiers in aging neuroscience

Published: November 05, 2025

Natural history and clinical impact of epilepsy in adults with Down syndrome: a multicentre clinical study.

Natural history and clinical impact of epilepsy in adults with Down syndrome: a multicentre clinical study.

Journal: Lancet (London, England)

Published: October 31, 2025

Temporal dynamics of white matter hyperintensities related to Alzheimer's disease in adults with Down syndrome.

Temporal dynamics of white matter hyperintensities related to Alzheimer's disease in adults with Down syndrome.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: October 22, 2025

Factors impacting survival in individuals with Down syndrome-associated Alzheimer's disease.

Factors impacting survival in individuals with Down syndrome-associated Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: October 09, 2025

Plasma p-tau217 as a biomarker of Alzheimer's disease pathology in individuals with Down syndrome.

Plasma p-tau217 as a biomarker of Alzheimer's disease pathology in individuals with Down syndrome.

Journal: Nature communications

Published: July 23, 2025

Association of Plasma Phosphorylated Tau 217 With Clinical Deterioration Across Alzheimer Disease Stages.

Association of Plasma Phosphorylated Tau 217 With Clinical Deterioration Across Alzheimer Disease Stages.

Journal: Neurology

Published: June 05, 2025

Showing 1-12 of 31

Last Updated: 09/26/2026